Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial - Silverberg, JI; Simpson, EL; Thyssen, JP (JAMA Dermatol, 2020)
et al.